This meeting will provide an ideal opportunity for “payers” and other decision makers from both public and private organisations, to benchmark with peers internationally and provide pharma companies an invaluable insight into the decision making processes and approaches of these vital stakeholders. Attendees will be able to understand and develop best practice approaches to such vital and common challenges, with the ultimate goal of encouraging innovation and improving patient access to novel and powerful medications.5 EVENTS IN ONE:Pharmaceutical Payers and HTA SummitInnovative Pricing & Reimbursement AgreementsMarket Access for High Value Oncology TherapeuticsBest Practices in Economic Modeling to Demonstrate Superior Outcomes & ValueManaged Entry Agreement (Workshop)